Home genetic testing may lead to exaggerating breast cancer risks
- Some people use consumer genetics testing to discover vulnerabilities
- But a new study shows this testing may have flaws
- In particular, researchers found it may exaggerate breast cancer risk
ovp test
Male shot by female at Shreveport apartment
Class to create biodiverse backyard
Rules for outbursts at Caddo School Board Meeting
(NewsNation) — A new study suggests that consumer genetic testing may be leading people to exaggerate their breast cancer risks.
The study, conducted by a group of British researchers, noted that women who find that they have a variant of BRCA 1 or BRCA 2 genes may be informed that their risk of breast cancer is between 60% and 80%.
But the study’s analysis suggests that the risk may be closer to 20% of the women don’t have a close relative who has breast cancer.
“Being told you are at high genetic risk of disease can really influence levels of fear of a particular condition and the resulting action you may take,” said the University of Exeter’s Dr. Leigh Jackson, who worked on the study. “Up to 80% risk of developing breast cancer is very different from 20%.”
One expert responded to the study by reiterating the need to consult with experts before making medical decisions.
“We would highly recommend that anyone found to have a hereditary cancer gene mutation via [Direct to Consumer] genetic testing consult with a cancer genetics expert prior to making any medical management decisions, particularly preventative surgery,” Courtney Rowe-Teeter, a genetics counselor at Stanford Cancer Genetics Clinic, said.
